Wogonin Induced Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Human Malignant Neuroblastoma Cells Via IRE1α-Dependent Pathway

Journal of Molecular Neuroscience : MN
Wenliang GeHua Xian

Abstract

Wogonin, a flavonoid isolated from Scutellaria baicalensis Georgi, has been reported to exhibit a variety of biological effects including anti-cancer effects. It has a pro-apoptotic role in many cancer types. However, the molecular mechanisms of wogonin in treating neuroblastoma remain elusive. In the present study, two malignant neuroblastoma cell lines (SK-N-BE2 and IMR-32 cells) were treated with different doses of wogonin (0-150 μM). Wogonin showed significant cytotoxic effects in SK-N-BE2 and IMR-32 cells in a dose- and time-dependent manner. Treatment of SK-N-BE2 and IMR-32 cells with 75 μΜ wogonin for 48 h significantly promoted apoptosis, the release of cytochrome c, altered the expression of certain members of Bcl-2 family (Bcl-2, Bax and Bid), and increased the activation of caspase-3, caspase-8, caspase-9, and PARP-1, which demonstrated that the cytotoxic effect of wogonin in SK-N-BE2 and IMR-32 cells is mediated by mitochondrial dysfunction. Moreover, wogonin induced the expression of endoplasmic reticulum (ER) stress-related proteins (GRP78/Bip and GRP94/gp96) and activation of caspase-12 and caspase-4 in SK-N-BE2 and IMR-32 cells. In addition, wogonin increase the expression of IRE1α and TRAF2, and phosphorylation...Continue Reading

References

Mar 18, 2000·The Journal of Nutrition·G J KelloffC C Sigman
Mar 4, 2003·Nature Reviews. Cancer·Garrett M Brodeur
Nov 25, 2003·Oncogene·David G BreckenridgeGordon C Shore
Feb 19, 2004·The Journal of Biological Chemistry·Shazia IrshadVishwanie Budhram-Mahadeo
Nov 30, 2005·Journal of Internal Medicine·B Fadeel, S Orrenius
Jan 7, 2006·Cell Death and Differentiation·M Boyce, J Yuan
Dec 18, 2007·Molecular Cell·Pascal Meier, Karen H Vousden
Dec 22, 2007·Nature Reviews. Molecular Cell Biology·Richard J Youle, Andreas Strasser
Jan 20, 2009·Current Medicinal Chemistry·M V ChiantoreG Romeo
Oct 14, 2009·Current Opinion in Cell Biology·Dirk Brenner, Tak W Mak
Jan 13, 2011·CNS & Neurological Disorders Drug Targets·Kazimierz GasiorowskiGjumrakch Aliev
Jan 19, 2012·Nature Reviews. Molecular Cell Biology·Claudio Hetz
Sep 6, 2012·International Journal of Molecular Sciences·Cheng-Fang TsaiDah-Yuu Lu
Jan 9, 2013·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Min XuQinglong Guo
Dec 18, 2013·International Journal of Molecular Sciences·Li Qing DuQiang Liu
Dec 18, 2013·Molecular Medicine Reports·Ke HeGuoan Xiang
Dec 24, 2013·Journal of Molecular Neuroscience : MN·Yue XuXiaoling Liang

❮ Previous
Next ❯

Citations

Apr 11, 2017·Cancer Chemotherapy and Pharmacology·Qiang WangHui Ding
Jan 2, 2019·Cancers·Mariam AbotalebDietrich Büsselberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.